#JPM22 - Deal­mak­ing in 2022: What's Big Phar­ma look­ing for and what is it will­ing to pay?

John Car­roll:

Okay, well, thanks every­body for com­ing out to­day. We had a ton of reg­is­tra­tions for this pan­el dis­cus­sion about deal­mak­ing in 2022. I think that every year is a big year when it comes to deal­mak­ing, M&A, and busi­ness de­vel­op­ment deals. And we’re cer­tain­ly see­ing a lot of in­ter­est this year, par­tic­u­lar­ly af­ter a very in­ter­est­ing 2021 — set the stage for a lot of peo­ple look­ing at where they’re at in terms of strat­e­gy, and how they po­si­tion their com­pa­ny go­ing in­to the new year.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN